As new cancer treatments become available, some of the most important ongoing research must look at ways to optimize those new approaches so that more patients
As new cancer treatments become available, some of the most important ongoing research must look at ways to optimize those new approaches so that more patients
A research study led by a multidisciplinary team of scientists at Roswell Park Comprehensive Cancer Center details evidence on the therapeutic efficacy of a com
The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation to Canget BioTekpharma LLC for FL118, a drug candidate developed at Roswell Park
Subcutaneous injection of the immunotherapy nivolumab (brand name Opdivo) is noninferior to intravenous delivery and dramatically reduces treatment time in pati